Mosapride

ApprovedSmall molecule

SSeoul National University Hospital

Mosapride is one of 168 small molecule programs targeting Gastroparesis. It is currently in Approved.

Indications

Total Trials

Active Trials

167

Competitors

Pipeline

Status by Indication[3][1]

Indication

GastroparesisActive, not recruiting

DyspepsiaActive, not recruiting

Colorectal CancerActive, not recruiting

Type 2 DiabetesActive, not recruiting

Irritable Bowel SyndromeActive, not recruiting

GastroparesisApproved

Active, not recruiting

DyspepsiaApproved

Active, not recruiting

Colorectal CancerPreclinical

Active, not recruiting

Type 2 DiabetesApproved

Active, not recruiting

Irritable Bowel SyndromeApproved

Active, not recruiting

Competition

Competitive Landscape

949 competitors in Colorectal Cancer

#DrugCompanyPhaseTrials

Mosapride

SSeoul National University Hospital

Approved

1 2

Eylea

Regeneron

Preclinical

5 3

PORTRAZZA

Vascepa

1 5

Gas-X

PPortuguese Oncology Institute, Coimbra

Preclinical

1 6

Ketalar

AAultman Health Foundation

Preclinical

1 7

Xylocaine

MMEDRx USA, Inc.

Preclinical

1 8

Versed

CConrado Roberto Hoffmann Filho

Preclinical

1 9

Ultiva

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

1 10

Bridion

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Constipation2 trials

Electroacupuncture for the Treatment of Functional Constipation

Unknown status·HHuazhong University of Science and Technology·Phase 1·NCT01781897·243 enrolled

Deep Needling at Zhongliao Point to Stimulate the Sacral Nerve for the Treatment of Slow Transit Constipation

Unknown status·GGuoliang Wu·N/A·NCT06156995·70 enrolled

Postoperative Ileus1 trial

Effect of Mosapride on Postoperative Ileus in Patients Undergoing Colorectal Surgery

Unknown status·HHospital Italiano de Buenos Aires·Phase 4·NCT02056405·90 enrolled

Irritable Bowel Syndrome1 trial

Effect of Mosapride on Gut Transit in Patients With Chronic Constipation or Constipated Irritable Bowel Syndrome and Healthy Subjects

Unknown status·SSeoul National University Hospital·Phase 4·NCT02433847·20 enrolled

Type 2 Diabetes1 trial

A Clinical Trial Analyzing Effects of Prokinetic Drug on the Blood Glucose in Patients With Type 2 Diabetes

Unknown status·TThird Military Medical University·Phase 4·NCT02606617·200 enrolled

Recovery1 trial

Mouth Dissolving Mosapride Tables Enhance Post Cesarean Gut Recovery

Completed·—·Phase 3·NCT03477266·400 enrolled

4 more indications

Dyspepsia1 trial

Lansoprazole Versus Mosapride for Functional Dyspepsia

Completed·LLotung Poh-Ai Hospital·Phase 4·NCT00663897·329 enrolled

Gastroparesis1 trial

Effects and Mechanism of Mosapride Citrate on Diabetic Gastroparesis

Unknown status·LLiangzhou Wei·Phase 4·NCT02264587·60 enrolled

Gastrectomy1 trial

Efficacy Study of a Low Volume of Water Intake and Mosapride for Endoscopy in Patients With Subtotal Gastrectomy

Completed·IInje University·Phase 3·NCT01284764·144 enrolled

Colorectal Cancer1 trial

Efficacy of Mosapride on Recovery of Intestinal Motility After Elective Colorectal Cancer Surgery

Unknown status·MMahidol University·N/A·NCT04905147·44 enrolled

Sources

References

[1]
ClinicalTrials.gov — 10 trial records for Mosapride. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Mosapride compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Mosapride. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Seoul National University Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: SSeoul National University Hospital

Mosapride

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Constipation2 trials

Postoperative Ileus1 trial

Irritable Bowel Syndrome1 trial

Type 2 Diabetes1 trial

Recovery1 trial

Dyspepsia1 trial

Gastroparesis1 trial

Gastrectomy1 trial

Colorectal Cancer1 trial

References

Drug Info

Quick Facts

Related News